Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells - Test2 - elhamkhani - TriplyDB

Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells

Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells

http://www.wikidata.org/entity/Q24617599

about

An enhanced H/ACA RNP assembly mechanism for human telomerase RNA Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs Telomeres and immune competency Telomere regulation in pluripotent stem cells Signals controlling Cajal body assembly and function Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency Single-stranded DNA-binding proteins: multiple domains for multiple functions Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells Structure of the Shq1-Cbf5-Nop10-Gar1 complex and implications for H/ACA RNP biogenesis and dyskeratosis congenita Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering Reevaluation of the safety of induced pluripotent stem cells: a call from somatic mosaicism A balance between elongation and trimming regulates telomere stability in stem cells WDR79 promotes the proliferation of non-small cell lung cancer cells via USP7-mediated regulation of the Mdm2-p53 pathway Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings.The role of nuclear bodies in gene expression and disease.The Cajal body and the nucleolus: "In a relationship" or "It's complicated"?Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.The promise of induced pluripotent stem cells in research and therapy Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock.Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita.The aging signature: a hallmark of induced pluripotent stem cells?Induced pluripotent stem cells in dermatology: potentials, advances, and limitations Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human cells.Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture.Adapting human pluripotent stem cells to high-throughput and high-content screening.Telomere elongation and naive pluripotent stem cells achieved from telomerase haplo-insufficient cells by somatic cell nuclear transfer.The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells.Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.TeloPIN: a database of telomeric proteins interaction network in mammalian cells Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis.Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling.Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita.The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres.Opportunities and Limitations of Modelling Alzheimer's Disease with Induced Pluripotent Stem Cells

P2860

Q24316597-8A5D49C7-8340-49BB-848D-A4E2FDD2DF37 Q26740026-D2BC75C1-022D-41D8-B5AF-437E42564580 Q26751506-DFB15470-558C-4DF7-99E5-C3329C88FF5C Q26775061-D14A9E62-F1ED-446D-A269-4F067AFE6FA4 Q26775122-BBC534E6-B09A-45FA-AD2A-97844352DAB2 Q26825318-046B82F6-2FC4-469A-9BEB-F1A2E3FFA370 Q26851428-8F22AA94-71A2-4A5F-B7A0-6D8E6A414A23 Q27003278-FAA9B283-221A-4A5A-8028-883668431360 Q27008903-3E67A888-0C3B-4A74-B7D9-382BB8E4AF0D Q27027869-A39B0287-23E5-4ECE-9D6F-063919B5864A Q27310384-4070FCFC-9B46-4C0C-AC2E-20EE53A0B7C9 Q27675803-19DBAD4F-5022-48F7-A318-7B630BD72EF8 Q28083303-63889223-33B0-4C9B-84EA-7C22A7B7C989 Q28394874-9E2E1DDF-7F5E-42DB-874D-91108FFAD323 Q28771742-A9ADF416-2471-43CE-8F60-ACBD5874A89D Q33815907-695669B2-F4AF-4CDB-AD89-A2DA78DA795B Q34019921-979C83D2-BD68-4926-AF99-1ECA30B97599 Q34038183-52D33B2F-165F-42F9-B284-ECF52CECECE8 Q34047421-ADBD384A-347F-44F2-AAB6-75B2DDE3255B Q34231818-0A16DB14-1ABA-48C3-9D67-6593499C23AD Q34248218-4F80365D-EE4B-45F7-A5A3-6FB2FC0BE007 Q34248727-B2FF3812-2AD4-4462-95AF-C94705982468 Q34255048-D13A0DB1-A9EC-441C-8F79-DE1CF31763C3 Q34386434-A4A028B2-B464-46BF-A472-92033E884361 Q34400271-7758831B-D798-43DF-9424-3A4EA569D9D4 Q34459333-7C3CD9F7-8A4F-4514-80A6-F36E615746E2 Q34498165-FCA36BED-A76C-4E5B-AEC9-2514190DC4B0 Q34519522-2C69AACE-3138-4078-83BA-7F18E0576684 Q34715193-C4A665F2-F98B-4828-B9AC-929CBA697544 Q34729447-2FE01B1C-6B70-4C00-9F6A-5A2554458EFB Q35029446-AB5ED34E-6D0F-4166-80D4-7DF51B5CF75E Q35037783-8028732B-C2C1-463D-98B0-962B54AA3195 Q35193008-64DE7CAE-1B7C-47A5-AFD5-42DCAC8E4C08 Q35256535-9D14CD8B-4FB4-4192-8CAF-58EAA9550F27 Q35320368-BB874D5D-D033-44A2-951B-26491AEE0E86 Q35563251-1163AD37-B255-4E01-87F9-69759F490D1B Q35620795-15852727-F830-49DC-B488-0B9BDF8A7855 Q35688622-AA9B0046-D4BE-498D-8584-1E1F4101C2F9 Q35729880-26A0BBC7-115C-4397-89CD-6216D8687678 Q35750557-3CC6AB4E-075B-431D-9236-E3B010088795

P2860

Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells

http://www.wikidata.org/entity/Q24617599

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Telomere shortening and loss o ...... induced pluripotent stem cells

@ast

Telomere shortening and loss o ...... induced pluripotent stem cells

@en

Telomere shortening and loss o ...... induced pluripotent stem cells

@nl

type

label

Telomere shortening and loss o ...... induced pluripotent stem cells

@ast

Telomere shortening and loss o ...... induced pluripotent stem cells

@en

Telomere shortening and loss o ...... induced pluripotent stem cells

@nl

prefLabel

Telomere shortening and loss o ...... induced pluripotent stem cells

@ast

Telomere shortening and loss o ...... induced pluripotent stem cells

@en

Telomere shortening and loss o ...... induced pluripotent stem cells

@nl

P1433

Q24617599-983BD58C-E09A-427E-9453-6126A83636BA

P1476

Q24617599-1ECFEC75-8449-47EC-AE97-508607BA875E

P2093

Q24617599-0C0E36D4-6290-4F8B-BB4A-0FC0B1107E23

Q24617599-3A47E179-8E4F-4534-8AB6-43466CB9AB8D

Q24617599-5719DEAB-8BE0-4B40-BF17-F137925C96C4

Q24617599-5A2447DB-C9C5-4511-A188-C18A9A2D0621

Q24617599-5B7E8133-C86C-4A95-A4D8-4BC32D1B0695

Q24617599-5EFC5C04-0D4D-4580-AC48-3857A6224D79

Q24617599-7246ECC5-7295-4776-AE44-C6E0801D6679

Q24617599-C695DCAC-4E86-44D6-BFD3-A7E5983E771A

Q24617599-DF84632B-BED8-434F-9D33-176A092D5CC3

Q24617599-E9B5FE47-74E0-44CE-AA45-5A3C0404F874

P2860

Q24617599-09B6D7A3-D33B-4901-89F0-48024FA5C66F

Q24617599-15D68C26-AC0F-4A2D-A07B-6EA09D359FC7

Q24617599-179C5C4C-7F66-4EE6-B265-D9874E4176B3

Q24617599-19C8B0A1-3C44-40BB-8AF1-821CDDDCC211

Q24617599-1CEC9C45-98DF-45F4-8693-D88D1DEC54AC

Q24617599-2B82DDBB-38FB-41BB-978E-9A3F67385866

Q24617599-31101611-76CD-4DDD-B998-D0F2185EB88D

Q24617599-35722C19-1F57-4A34-91AC-604642E53C94

Q24617599-402BFF37-7266-4DE4-9360-2CB00FD12F47

Q24617599-40E19DC8-9B66-4252-8919-828B2F48B0E1

P2888

Q24617599-3435CF6C-2CE7-4F44-9BB9-7C5264F00FA4

P304

Q24617599-A95FFFAC-EBE4-4BDF-815F-5AC97C0024E1

P31

Q24617599-1432CA27-46C2-4E70-AF67-795EC358B62A

P3181

Q24617599-268CCB95-AC49-4582-B60A-DF4354910860

P356

Q24617599-D184B2CE-2C52-48B8-A8A4-433098C82782

P407

Q24617599-EA8AA0BF-3013-4326-96EA-01FF58C00F64

P433

Q24617599-68F62B95-1779-47C8-808E-4A208F0CD743

P478

Q24617599-6F9F4655-A362-4BB7-875B-1110C2FBEAA1

P50

Q24617599-01EA7323-B832-469F-BA62-88C3BFC40D94

Q24617599-3CE1C3A6-BB81-4E7E-98DC-BA1E490E1F66

Q24617599-74A18896-130C-4F4C-9657-A5DE86CFDF37

Q24617599-852253C6-FE78-48CF-9B80-DFFA21D21496

Q24617599-861DABA2-DFE3-40A2-BAA7-CF86FB01DB4D

Q24617599-8A5126F7-3838-47FA-BCB4-C5F866E1DE7D

Q24617599-C58F6453-9D3B-45E0-866C-F6AA4DF0A37D

P577

Q24617599-900D8857-BC71-44CD-9F16-259CEFE2EDF5

P5875

Q24617599-EA97DEDD-BA72-4E72-8B11-B86E2C900FE0

P6179

Q24617599-28B199E5-724D-49C2-8BF9-3B7BBCAD6915

P698

Q24617599-21139774-12E2-44FE-AF52-2214E947E2A2

P932

Q24617599-45371CD7-77A6-4ECB-836A-D7894365E538

P3181

P356

P1433

P1476

Telomere shortening and loss o ...... induced pluripotent stem cells

@en

P2093

Blanche P Alter

http://www.w3.org/2001/XMLSchema#string

Franklin L Zhong

http://www.w3.org/2001/XMLSchema#string

Ha Nam Nguyen

http://www.w3.org/2001/XMLSchema#string

Jinkuk Choi

http://www.w3.org/2001/XMLSchema#string

Luis F Z Batista

http://www.w3.org/2001/XMLSchema#string

Matthew F Pech

http://www.w3.org/2001/XMLSchema#string

Neelam Giri

http://www.w3.org/2001/XMLSchema#string

Sharon M Crary

http://www.w3.org/2001/XMLSchema#string

Steven E Artandi

http://www.w3.org/2001/XMLSchema#string

Vittorio Sebastiano

http://www.w3.org/2001/XMLSchema#string

P2860

A telomerase component is defective in the human disease dyskeratosis congenita

Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs

The POT1-TPP1 telomere complex is a telomerase processivity factor

Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly

A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis

Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita

Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients

Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita

Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

P2888

P304

399-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1066614

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE10084

http://www.w3.org/2001/XMLSchema#string

P407

P433

7351

http://www.w3.org/2001/XMLSchema#string

P478

474

http://www.w3.org/2001/XMLSchema#string

P50

Renee Reijo Pera

P577

2011-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51156413

http://www.w3.org/2001/XMLSchema#string

P6179

1005531889

http://www.w3.org/2001/XMLSchema#string

P698

21602826

http://www.w3.org/2001/XMLSchema#string

P932

3155806

http://www.w3.org/2001/XMLSchema#string